Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study

doi:10.5527/wjn.v15.i1.113599

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

(33)

(35)

(0)

(1)

(818)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Nephrol. Mar 25, 2026; 15(1): 113599
Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.113599

Full Size Figure Download Figure

Figure 1 Renin-angiotensin-aldosterone system inhibitors subcategory days supply in patients by patiromer adherence. RAASi: Renin-angiotensin-aldosterone system inhibitors; ACEi: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin II receptor blocker; MRA: Mineralocorticoid receptor antagonist; DRi: Direct renin inhibitor; PDC: Proportion of days covered.

Citation: Kleinman N, Desai T, Thakar C. Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study. World J Nephrol 2026; 15(1): 113599
URL: https://www.wjgnet.com/2220-6124/full/v15/i1/113599.htm
DOI: https://dx.doi.org/10.5527/wjn.v15.i1.113599

Kleinman N, Desai T, Thakar C. Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study. World J Nephrol 2026; 15(1): 113599 [PMID: 41884247 DOI: 10.5527/wjn.v15.i1.113599]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.